Mylan NV (NASDAQ:MYL)

37.82
Delayed Data
As of Aug 15
 -0.70 / -1.82%
Today’s Change
29.39
Today|||52-Week Range
47.82
-10.61%
Year-to-Date

Today’s Trading

Previous close38.52
Today’s open38.19
Day’s range37.72 - 38.46
Volume4,397,630
Average volume (3 months)4,656,302
Market cap$19.9B
Data as of 4:00pm ET, 08/15/2018

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+5.27%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+7.06%
P/E ratio44.0
Price/Sales1.91
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-1.33-1.29%
PRGOPerrigo Company PLC-0.01-0.01%
JAZZJazz Pharmaceuticals...-2.31-1.31%
ALNYAlnylam Pharmaceutic...-1.96-2.10%
Data as of 4:01pm ET, 08/15/2018

Financials

Next reporting dateNovember 1, 2018
EPS forecast (this quarter)$1.40
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts